Embedded Files
Objective
Objective
To accelerate Thailand’s national capability in biotechnology, genomics, and medical R&D through the development of advanced life science ecosystems, precision medicine platforms, biomedical innovation systems, and future healthcare technologies.
The framework aims to strengthen Thailand’s competitiveness within:
biotechnology
genomics
pharmaceutical innovation
regenerative medicine
precision healthcare
and medical AI ecosystems
through the integration of:
research infrastructure
genomic data platforms
clinical research systems
bioinformatics
biotechnology commercialization
and international scientific collaboration.
The initiative also seeks to position Thailand as:
ASEAN Biomedical Innovation Hub
Regional Genomics Platform
and Future Precision Medicine Economy Leader
while strengthening long-term healthcare resilience, innovation sovereignty, and strategic medical capability.
Action
Action
Develop National Biotech & Genomics Framework integrating:
biotechnology research
genomics platforms
biomedical laboratories
AI-driven medical analytics
pharmaceutical R&D
and clinical innovation ecosystems.
Strengthen national capability in:
genomic sequencing
precision medicine
bioinformatics
molecular diagnostics
cell & gene therapy
regenerative medicine
and biomarker discovery systems.
Establish Biotech & Medical Innovation Clusters connected with:
universities
hospitals
pharmaceutical firms
biotech startups
AI developers
and international research institutions.
Accelerate development of:
genomic databases
national biobank systems
medical data platforms
clinical trial infrastructure
and translational medical research ecosystems.
Support commercialization and scaling of:
biotech startups
pharmaceutical innovation
medical AI platforms
advanced diagnostics
and biotechnology manufacturing systems.
Integrate AI and digital systems into:
genomics analytics
drug discovery
predictive medicine
personalized treatment systems
and biomedical research automation.
Strengthen international cooperation in:
medical R&D
pharmaceutical innovation
biotechnology investment
clinical research
and future healthcare technologies.
Position Thailand as:
ASEAN Biomedical Innovation Hub
Regional Precision Medicine Platform
and Genomics-Driven Healthcare Economy Leader.
Expected Output
Expected Output
Thailand develops advanced capability within:
biotechnology
genomics
biomedical innovation
and precision healthcare ecosystems.
New industries emerge in:
genomics services
regenerative medicine
biotechnology manufacturing
medical AI
and advanced pharmaceutical innovation.
The country strengthens:
healthcare resilience
medical innovation sovereignty
scientific competitiveness
and long-term biomedical capability.
Thailand improves readiness for:
personalized healthcare
advanced therapeutics
precision medicine
and future healthcare transformation.
The country gains stronger positioning within:
global life science ecosystems
biomedical supply chains
pharmaceutical innovation markets
and future healthcare economies.
Objective
Objective
ยกระดับขีดความสามารถของประเทศไทยด้าน:
biotechnology
genomics
medical R&D
และ precision medicine ecosystem
ผ่านการพัฒนา:
advanced life science infrastructure
biomedical innovation system
clinical research ecosystem
AI-driven medical analytics
และ future healthcare technology
Framework นี้มีเป้าหมายในการเสริม competitiveness ของประเทศไทยใน:
biotechnology
pharmaceutical innovation
regenerative medicine
genomics
precision healthcare
และ medical AI ecosystem
ผ่านการบูรณาการ:
research infrastructure
genomic data platform
clinical research system
bioinformatics
biotechnology commercialization
และ international scientific collaboration
พร้อมวาง positioning ประเทศไทยสู่:
ASEAN Biomedical Innovation Hub
Regional Genomics Platform
และ Future Precision Medicine Economy Leader
Action
Action
พัฒนา National Biotech & Genomics Framework เชื่อม:
biotechnology research
genomics platform
biomedical laboratory
AI-driven medical analytics
pharmaceutical R&D
และ clinical innovation ecosystem
เข้าเป็น ecosystem เดียวกัน
ยกระดับ national capability ด้าน:
genomic sequencing
precision medicine
bioinformatics
molecular diagnostics
cell & gene therapy
regenerative medicine
และ biomarker discovery system
จัดตั้ง Biotech & Medical Innovation Cluster เชื่อม:
university
hospital
pharmaceutical firm
biotech startup
AI developer
และ international research institution
เร่งพัฒนา:
genomic database
national biobank system
medical data platform
clinical trial infrastructure
และ translational medical research ecosystem
สนับสนุน commercialization และ scaling ของ:
biotech startup
pharmaceutical innovation
medical AI platform
advanced diagnostics
และ biotechnology manufacturing system
บูรณาการ AI และ digital system เข้ากับ:
genomics analytics
drug discovery
predictive medicine
personalized treatment system
และ biomedical research automation
ยกระดับ international cooperation ด้าน:
medical R&D
pharmaceutical innovation
biotechnology investment
clinical research
และ future healthcare technology
วาง positioning ประเทศไทยสู่:
ASEAN Biomedical Innovation Hub
Regional Precision Medicine Platform
และ Genomics-Driven Healthcare Economy Leader
Expected Output
Expected Output
ประเทศไทยมี advanced capability ด้าน:
biotechnology
genomics
biomedical innovation
และ precision healthcare ecosystem
เกิดอุตสาหกรรมใหม่ในด้าน:
genomics service
regenerative medicine
biotechnology manufacturing
medical AI
และ advanced pharmaceutical innovation
ประเทศมี:
healthcare resilience สูงขึ้น
medical innovation sovereignty แข็งแรงขึ้น
scientific competitiveness สูงขึ้น
และ long-term biomedical capability ดีขึ้น
ประเทศไทยมี readiness สูงขึ้นสำหรับ:
personalized healthcare
advanced therapeutics
precision medicine
และ future healthcare transformation
ประเทศมี positioning สูงขึ้นใน:
global life science ecosystem
biomedical supply chain
pharmaceutical innovation market
และ future healthcare economy
Page updated
Google Sites
Report abuse